.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Army
Mallinckrodt
Moodys
Julphar
Argus Health
Accenture
McKinsey
Merck
Teva

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076145

« Back to Dashboard
NDA 076145 describes FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, which is a drug marketed by Hikma Farmaceutica, Fresenius Kabi Usa, Baxter Hlthcare Corp, Teva Pharms Usa, West-ward Pharms Int, Hospira, Acs Dobfar Info Sa, Renaissance Ssa Llc, Teva Pharms, Baxter Hlthcare, and Mylan Labs Ltd, and is included in fourteen NDAs. It is available from two suppliers. Additional details are available on the FLUCONAZOLE IN SODIUM CHLORIDE 0.9% profile page.

The generic ingredient in FLUCONAZOLE IN SODIUM CHLORIDE 0.9% is fluconazole. There are twenty-three drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the fluconazole profile page.

Summary for 076145

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength200MG/100ML (2MG/ML)
Approval Date:Jul 29, 2004TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength400MG/200ML (2MG/ML)
Approval Date:Jul 29, 2004TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
Dow
Fish and Richardson
Federal Trade Commission
Moodys
US Department of Justice
QuintilesIMS
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot